|
|
|
42
|
1306BT
|
ASPIRIN 81MG TAB (HEA)
|
ASPIRIN
|
ASPIRIN
|
1000'S
|
A
|
33.63
|
0.03
|
TAB
|
60
|
BLIS
|
HEA
|
HEALTH 2000 INC
|
CWS
|
CAPSULE WHOLESALE
|
|
28080424
|
SALICYLATES
|
2026-04-01
|
|
Add to Contract as Cat A
|
ORAL
|
6
|
SALICYLATES
|
2026-01-26
|
|
|
|
42
|
1306BU
|
ASPIRIN EC 81MG TAB (HEA)
|
ASPIRIN
|
ASPIRIN EC
|
100X10
|
A
|
33.63
|
0.03
|
TAB
|
60
|
|
HEA
|
HEALTH 2000 INC
|
STO
|
BRYDEN STOKES LTD
|
|
28080424
|
SALICYLATES
|
2026-04-01
|
|
Add to Contract as Cat A
|
ORAL
|
6
|
SALICYLATES
|
2026-02-27
|
|
|
|
40
|
1321G
|
CODEINE PHOSPHATE 15MG TAB (TEV/COL)
|
CODEINE PHOSPHATE
|
CODEINE PHOSPHATE
|
28'S
|
A
|
5.03
|
0.18
|
TABLET
|
112
|
TAB
|
TEV
|
TEVA UK LTD.
|
COL
|
COLLINS LTD
|
|
280808
|
OPIATE AGONISTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
2
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
1321G
|
CODEINE PHOSPHATE 15MG TAB (TEV)
|
CODEINE PHOSPHATE
|
CODEINE PHOSPHATE
|
28'S
|
A
|
4.7
|
0.168
|
TAB
|
112
|
BOX
|
TEV
|
TEVA UK LTD.
|
COL
|
COLLINS LTD
|
|
280808
|
OPIATE AGONISTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
2
|
OPIATE AGONISTS
|
|
|
|
|
42
|
1321J
|
CODEINE PHOSPHATE 15MG TAB (CPP)
|
CODEINE PHOSPHATE
|
CODEINE PHOSPHATE
|
28'S
|
A
|
4.00
|
0.14
|
TAB
|
112
|
BLIS
|
CPP
|
WOCKHARDT UK LTD
|
COL
|
AVENTA BARBADOS
|
|
280808
|
OPIATE AGONISTS
|
2026-04-01
|
|
|
ORAL
|
2
|
OPIATE AGONISTS
|
|
|
|
|
40
|
1322L
|
CODEINE PHOSPHATE 30MG TAB (TEV/COL)
|
CODEINE PHOSPHATE
|
CODEINE PHOSPHATE
|
28'S
|
A
|
6.85
|
0.24
|
TABLET
|
112
|
TAB
|
TEV
|
TEVA UK LTD.
|
COL
|
COLLINS LTD
|
|
280808
|
OPIATE AGONISTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
2
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
1322L
|
CODEINE PHOSPHATE 30MG TAB (TEV)
|
CODEINE PHOSPHATE
|
CODEINE PHOSPHATE
|
28'S
|
A
|
5.76
|
0.2058
|
TAB
|
112
|
BOX
|
TEV
|
TEVA UK LTD.
|
COL
|
COLLINS LTD
|
|
280808
|
OPIATE AGONISTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
2
|
OPIATE AGONISTS
|
|
|
|
|
42
|
1322M
|
CODEINE PHOSPHATE 30MG TAB (CPP)
|
CODEINE PHOSPHATE
|
CODEINE PHOSPHATE
|
28'S
|
A
|
6.36
|
0.23
|
TAB
|
112
|
BLIS
|
CPP
|
WOCKHARDT UK LTD
|
COL
|
AVENTA BARBADOS
|
|
280808
|
OPIATE AGONISTS
|
2026-04-01
|
|
|
ORAL
|
2
|
OPIATE AGONISTS
|
|
|
|
|
41
|
1322R
|
CODEINE PHOSPHATE 30MG TAB (CPP)
|
CODEINE PHOSPHATE
|
CODEINE PHOSPHATE
|
3X10
|
A
|
4.4
|
0.1468
|
TAB
|
112
|
BOX
|
CPP
|
WOCKHARDT UK LTD
|
COL
|
COLLINS LTD
|
|
280808
|
OPIATE AGONISTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
2
|
OPIATE AGONISTS
|
|
|
|
|
40
|
13235
|
CODEINE PHOSPHATE 30MG/ML INJ (KWA/ATB)
|
CODEINE PHOSPHATE
|
CODEINE PHOSPHATE
|
10X1ML
|
C
|
203.87
|
20.39
|
INJECTION
|
0
|
AMP
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
280808
|
OPIATE AGONISTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
13235
|
CODEINE PHOSPHATE 30MG/ML INJ (KWA)
|
CODEINE PHOSPHATE
|
CODEINE PHOSPHATE
|
10X1ML
|
C
|
135.59
|
13.559
|
AMP
|
0
|
BOX
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
2808
|
ANALGESICS-ANTIPYRETICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANALGESICS-ANTIPYRETICS
|
|
|
|
|
41
|
13315
|
FENTANYL CITRATE 50MCG/ML INJ (RTM) (BQ)
|
FENTANYL CITRATE
|
FENTANYL CITRATE
|
10X2ML
|
BQ
|
24.85
|
2.4846
|
AMP
|
0
|
BOX
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
280808
|
OPIATE AGONISTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
OPIATE AGONISTS
|
|
|
|
|
42
|
13315
|
FENTANYL CITRATE 50MCG/ML INJ (RTM)
|
FENTANYL CITRATE
|
FENTANYL CITRATE
|
10X2ML
|
BQ
|
14.95
|
1.50
|
AMPG
|
0
|
BOX
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
280808
|
OPIATE AGONISTS
|
2026-04-01
|
|
|
IV
|
0
|
OPIATE AGONISTS
|
|
|
|
|
40
|
13319
|
FENTANYL CITRATE 50MCG/ML INJ (MTP/COL)
|
FENTANYL CITRATE
|
FENTANYL CITRATE
|
10X2ML
|
BQ
|
13.05
|
1.31
|
INJECTION
|
0
|
AMP
|
MTP
|
MARTINDALE PHARMACEUTICALS
|
COL
|
COLLINS LTD
|
|
280808
|
OPIATE AGONISTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
13319
|
FENTANYL CITRATE 50MCG/ML INJ (MTP) (BQ)
|
FENTANYL CITRATE
|
FENTANYL CITRATE
|
10X2ML
|
BQ
|
17.94
|
1.7941
|
AMP
|
0
|
BOX
|
MTP
|
MARTINDALE PHARMACEUTICALS
|
COL
|
COLLINS LTD
|
|
280808
|
OPIATE AGONISTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
OPIATE AGONISTS
|
|
|
|
|
40
|
1331K
|
FENTANYL CITRATE 50MCG/ML INJ (KWA/ATB)
|
FENTANYL CITRATE
|
FENTANYL CITRATE
|
10X2ML
|
BQ
|
25.17
|
0.25
|
INJECTION
|
0
|
AMP
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
280808
|
OPIATE AGONISTS
|
2022-04-01
|
2022-09-30
|
|
IV
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-03-30
|
|
|
|
41
|
1331K
|
FENTANYL CITRATE 50MCG/ML INJ (KWA) (BQ)
|
FENTANYL CITRATE
|
FENTANYL CITRATE
|
10X2ML
|
BQ
|
18.02
|
1.8022
|
AMP
|
0
|
BOX
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
280808
|
OPIATE AGONISTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
OPIATE AGONISTS
|
|
|
|
|
40
|
1331M
|
FENTANYL CITRATE 50MCG/ML INJ (SGH/COL)
|
FENTANYL CITRATE
|
FENTANYL CITRATE
|
10X2ML
|
BQ
|
13.59
|
1.36
|
INJECTION
|
0
|
AMP
|
SGH
|
SEIGFRIED-HAMELN
|
COL
|
COLLINS LTD
|
|
280808
|
OPIATE AGONISTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
13325
|
FENTANYL CITRATE 50MCG/ML INJ (RTM/PHA)
|
FENTANYL CITRATE
|
FENTANYL CITRATE
|
10X10ML
|
BQ
|
27.37
|
2.74
|
INJECTION
|
0
|
VIAL
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
280808
|
OPIATE AGONISTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
13325
|
FENTANYL CITRATE 50MCG/ML INJ (RTM) (BQ)
|
FENTANYL CITRATE
|
FENTANYL CITRATE
|
10X10ML
|
BQ
|
38.22
|
3.822
|
VIAL
|
0
|
BOX
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
280808
|
OPIATE AGONISTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
OPIATE AGONISTS
|
|